Enhancing immune responses using suicidal DNA vaccines
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 16 (6) , 562-565
- https://doi.org/10.1038/nbt0698-562
Abstract
We describe a DNA vaccine strategy that allows antigens to be produced in vivo in the context of an alphaviral replicon. Mice immunized with such vectors developed humoral and cellular immune responses at higher levels than mice that received a conventional DNA vaccine vector. Immunized animals acquired protective immunity to lethal influenza challenge. Compared with traditional DNA vaccine strategies in which vectors are persistent and the expression constitutive, the expression mediated by the alphaviral vector was transient and lytic. As a result, biosafety risks such as chromosomal integration, and the induction of immunological tolerance, could be circumvented.Keywords
This publication has 40 references indexed in Scilit:
- Long-term effects of Semliki Forest virus infection in the mouse central nervous systemNeuropathology and Applied Neurobiology, 1997
- DNA VACCINESAnnual Review of Immunology, 1997
- Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cellsGene Therapy, 1997
- DNA vaccinesLife Sciences, 1996
- Long life span of tolerant T cells and the role of antigen in maintenance of peripheral toleranceInternational Immunology, 1995
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cellsNature, 1990
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Neurogenic spread of Semliki forest virus in miceArchiv für die gesamte Virusforschung, 1987